rs751468762
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000055682.12(NEXMIF):c.3319G>A(p.Asp1107Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000314 in 1,209,376 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1107E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000055682.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.3319G>A | p.Asp1107Asn | missense_variant | 3/4 | ENST00000055682.12 | NP_001008537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.3319G>A | p.Asp1107Asn | missense_variant | 3/4 | 1 | NM_001008537.3 | ENSP00000055682 | P1 | |
NEXMIF | ENST00000616200.2 | c.3319G>A | p.Asp1107Asn | missense_variant | 3/5 | 1 | ENSP00000480284 | P1 | ||
NEXMIF | ENST00000642681.2 | c.3319G>A | p.Asp1107Asn | missense_variant | 3/3 | ENSP00000495800 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111356Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33528
GnomAD3 exomes AF: 0.0000655 AC: 12AN: 183316Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67796
GnomAD4 exome AF: 0.0000328 AC: 36AN: 1098020Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 9AN XY: 363390
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111356Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33528
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 02, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 1107 of the NEXMIF protein (p.Asp1107Asn). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 211264). This variant has not been reported in the literature in individuals affected with NEXMIF-related conditions. This variant is present in population databases (rs751468762, gnomAD 0.02%), including at least one homozygous and/or hemizygous individual. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 16, 2015 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2021 | The c.3319G>A (p.D1107N) alteration is located in exon 3 (coding exon 2) of the NEXMIF gene. This alteration results from a G to A substitution at nucleotide position 3319, causing the aspartic acid (D) at amino acid position 1107 to be replaced by an asparagine (N). Based on data from the Genome Aggregation Database (gnomAD) database, the NEXMIF c.3319G>A alteration was observed in 0.0065% (12/183,316) of total alleles studied, with a frequency of 0.018% (5/27,401) in the Latino subpopulation. The p.D1107N alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at